000 | 01651 a2200529 4500 | ||
---|---|---|---|
005 | 20250512041357.0 | ||
264 | 0 | _c19890104 | |
008 | 198901s 0 0 eng d | ||
022 | _a0004-4172 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aArmah, B I | |
245 | 0 | 0 |
_aGeneral pharmacology of the novel centrally acting antihypertensive agent moxonidine. _h[electronic resource] |
260 |
_bArzneimittel-Forschung _cOct 1988 |
||
300 |
_a1426-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 | _aCats |
650 | 0 | 4 | _aChemical Phenomena |
650 | 0 | 4 | _aChemistry |
650 | 0 | 4 |
_aClonidine _xadministration & dosage |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aDiuresis _xdrug effects |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastric Mucosa _xdrug effects |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aNorepinephrine _xblood |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred SHR |
650 | 0 | 4 | _aRats, Inbred Strains |
650 | 0 | 4 |
_aSalivation _xdrug effects |
700 | 1 | _aHofferber, E | |
700 | 1 | _aStenzel, W | |
773 | 0 |
_tArzneimittel-Forschung _gvol. 38 _gno. 10 _gp. 1426-34 |
|
999 |
_c3202167 _d3202167 |